Commentary regarding double‐blind placebo‐controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams‐Huet, DA Khan. J Allergy Clin Immunol Pract 2:601–606, 2014

Publisher: John Wiley & Sons Inc

E-ISSN: 1529-8019|28|2|102-103

ISSN: 1396-0296

Source: DERMATOLOGIC THERAPY, Vol.28, Iss.2, 2015-03, pp. : 102-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content